Clinical trial
Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?
NCT02900170 is registered in ClinicalTrials.gov with Albert Einstein Healthcare Network as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?
- Lead sponsor
- Albert Einstein Healthcare Network
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- June 11, 2018
- Enrollment
- 8 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.